Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 2 of 114

  1. 1305-0046

    Boehringer Ingelheim

    Systemic Autoimmune Rheumatic Diseases associated Interstitial Lung Diseases (SARD-ILD)

    phase 3 small molecule active

    1 trial

  2. 1305-0069

    Boehringer Ingelheim

    Interstitial lung diseases, Familial pulmonary fibrosis, Pulmonary fibrosis

    phase 3 small molecule active

    1 trial

  3. 131I-TLX-101-003

    Lacuna Pharma Pty Ltd

    Glioblastoma

    phase 3 small molecule active

    1 trial

  4. 131I-apamistamab

    Actinium Pharmaceuticals

    Acute Leukemia

    phase 3 small molecule active

    1 trial

  5. 13406

    Regeneron UK Limited

    Macular Degeneration

    phase 3 mab completed

    1 trial

  6. 1346-0014

    Boehringer Ingelheim

    Schizophrenia

    phase 3 other active

    1 trial

  7. 1378-0018

    Boehringer Ingelheim

    Heart failure

    phase 3 small molecule active

    1 trial

  8. 1378-0020

    Boehringer Ingelheim

    Heart failure (HF)

    phase 3 small molecule active

    1 trial

  9. 1378-0041

    Boehringer Ingelheim

    Type 2 diabetes, hypertension, cardiovascular disease

    phase 3 small molecule active

    1 trial

  10. 1403-0008

    Boehringer Ingelheim

    Advanced dedifferentiated liposarcoma

    phase 3 small molecule active

    1 trial

  11. 1403-0019

    Boehringer Ingelheim

    dedifferentiated liposarcoma

    phase 3 small molecule active

    1 trial

  12. 1404-0038

    Boehringer Ingelheim

    Obesity

    phase 3 small molecule active

    1 trial

  13. 1404-0040

    Boehringer Ingelheim

    Obesity

    phase 3 small molecule active

    1 trial

  14. 1404-0041

    Boehringer Ingelheim

    Obesity, Diabetes mellitus type II

    phase 3 small molecule active

    1 trial

  15. 1404-0056

    Boehringer Ingelheim

    Obesity

    phase 3 small molecule active

    1 trial

  16. 1407-GUCG

    Ningbo Cancer Hospital

    Progressive or recurrent germ cell tumor (measurable or non-measurable)

    phase 3 small molecule active

    1 trial

  17. 14130

    Regeneron UK Limited

    Retinal Vein Occlusion

    phase 3 mab completed

    1 trial

  18. 1414-ROG-GUCG

    Ningbo Cancer Hospital

    very high risk localized or locally advanced prostate cancer

    phase 3 small molecule active

    1 trial

  19. 1438-0011

    Boehringer Ingelheim

    advanced or metastatic extrapulmonary neuroendocrine carcinoma

    phase 3 small molecule active

    1 trial

  20. 1438-0012

    Boehringer Ingelheim

    small cell lung cancer

    phase 3 small molecule active

    1 trial

  21. 14395

    Disc Medicine

    ABC borderline resectable pancreatic cancer

    phase 3 other active

    1 trial

  22. 1479-0008

    Boehringer Ingelheim

    non-squamous non-small cell lung cancer

    phase 3 small molecule active

    1 trial

  23. 1479-0032

    Boehringer Ingelheim

    Non-small cell lung cancer

    phase 3 small molecule active

    1 trial

  24. 14V-MC-JAJK

    Eli Lilly Co.

    Diabetes Mellitus, Type 1

    phase 3 small molecule active

    1 trial

  25. 15161

    Regeneron UK Limited

    Macular Edema

    phase 3 mab completed

    1 trial

  26. 15161

    Bayer HealthCare AG

    Macular Edema

    phase 3 mab completed

    1 trial

  27. 156-201-00307

    Otsuka Beijing Research Institute

    Autosomal Recessive Polycystic Kidney Disease

    phase 3 small molecule active

    1 trial

  28. 160701

    Takeda

    Alzheimer´s Disease

    phase 3 mab completed

    1 trial

  29. 160902

    Takeda

    Primary Immunodeficiency Diseases (PID)

    phase 3 mab completed

    1 trial

  30. 161003

    Takeda

    Alzheimer´s Disease

    phase 3 mab terminated

    1 trial

  31. 161202

    Takeda

    Alzheimer´s Disease

    phase 3 small molecule terminated

    1 trial

  32. 165-306

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria (PKU)

    phase 3 small molecule active

    1 trial

  33. 17000139BLC3001

    Janssen-Cilag International N.V.

    Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder

    phase 3 small molecule active

    1 trial

  34. 17000139BLC3002

    Janssen-Cilag International N.V.

    High-Risk Non-muscle-invasive Bladder Cancer

    phase 3 small molecule active

    1 trial

  35. 17000139BLC3004

    Janssen-Cilag International N.V.

    High-Risk Non-muscle-invasive Bladder Cancer

    phase 3 small molecule active

    1 trial

  36. 170904

    Takeda

    Primary Immunodeficiency Diseases (PID)

    phase 3 mab completed

    1 trial

  37. 177Lu-TLX250

    Telix Innovations

    ccRCC

    phase 3 other active

    1 trial

  38. 177Lu-TLX591

    Telix Innovations

    Metastatic Castration-resistant Prostate Cancer

    phase 3 small molecule active

    1 trial

  39. 18-02/ClotriBet-C

    Alphapharm Pty Ltd

    moderate to severely inflamed candidiasis of the skin

    phase 3 other active

    1 trial

  40. 18-791

    Disc Medicine

    Brain injury in neonates with critical congenital heart disease requiring cardiac surgery with cardiopulmonary bypass.

    phase 3 small molecule active

    1 trial

  41. 1821-FSH-301

    Fulcrum Therapeutics

    Facioscapulohumeral Muscular Dystrophy (FSHD)

    phase 3 small molecule active

    1 trial

  42. 18F fluciclovine

    Chongqing Precision Biotech Co., Ltd

    Brain Metastases

    phase 3 small molecule completed

    2 trials

  43. 18F-AV-1451

    The George Institute

    Maladie d' Alzheimer, Alzheimer's pathology

    phase 3 small molecule active

    1 trial

  44. 18F-DPA-714

    Pari Pharma GmbH

    Multiple sclerosis

    phase 3 small molecule active

    1 trial

  45. 18F-LBT-999

    The George Institute

    Comatose Traumatic Brain Injury patients

    phase 3 small molecule active

    1 trial

  46. 192024-092

    AbbVie Deutschland GmbH & Co. KG

    Ocular hypertension, Open-angle glaucoma

    phase 3 small molecule active

    1 trial

  47. 19356A

    H. Lundbeck A/S

    Migraine

    phase 3 small molecule active

    1 trial

  48. 19920

    Bayer AG

    Proteinuria, Chronic kidney disease

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.